Paul Tudor Jones | Tudor Investment Corp Et Al

Fund Stats for Q4 2019Paul Tudor Jones is the managing partner of Tudor Investment Corp Et Al. The 13F filing for 2019 Q4 included $2.23B in managed 13F securities and a top 10 holdings concentration of 19.85%. Tudor Investment Corp Et Al's largest holding is Allergan Plc with shares held of 620.09K. 10kreader has 37 13F filings available for Tudor Investment Corp Et Al.Paul Tudor Jones is the managing partner of Tudor Investment Corp Et Al. The 13F filing for 2019 Q4 included $2.23B in managed 13F securities and a top 10 holdings concentration of 19.85%. Tudor Inves...

About Paul Tudor JonesPaul Tudor Jones II, founder and chief investment officer of Boston-based Tudor Investment Group, is one of the pioneers of the modern-day hedge fund industry. Jones began his career in the cotton pits before forming the firm in 1980. The guru was eager to create a firm differentiated by a steadfast dedication to client objectives and guided by strong ethics and values.While Tudor Investment is best known for our rich history in discretionary macro trading, the firm also has significant experience and capabilities in model-driven and systematic investment approaches. Management believes that firms must continually innovate in order to compete in rapidly evolving markets and thus, commits significant resources to research and development across a variety of strategies in order to expand the firm's edge. Ultimately, Tudor seeks to generate consistent returns for both client and proprietary capital through the use of best-in-class research, trading, and investment techniques.source: gurufocus.comPaul Tudor Jones II, founder and chief investment officer of Boston-based Tudor Investment Group, is one of the pioneers of the modern-day hedge fund industry. Jones began his career in the cotton pit...

Go to:

Company	Ticker	Market Value	% Portfolio	Shares	Change	Chg. Shares	Quarter End Price	Current Price	Yearly High	Yearly Low	Market Cap	% Owned
Allergan Plc		118.54M	5.32%	620.09K	10.43%	58.59K	$191.17
SPDR S&P 500 ETF TrustPut	SPY	88.23M	3.96%	274.10K	-62.23%	-451.60K	$321.88	$390.12	$479.98	$362.17	358.05B	0.03%
SPDR S&P 500 ETF Trust	SPY	66.62M	2.99%	206.99K	-8.55%	-19.36K	$321.86	$390.12	$479.98	$362.17	358.05B	0.02%
Caesars Entertainment, Inc.	CZR	32.86M	1.47%	2.42M	New	2.42M	$13.60	$46.65	$119.81	$35.1	10.00B	1.13%
Audentes Therapeutics IncPut		29.38M	1.32%	490.90K	New	490.90K	$59.84
Audentes Therapeutics Inc		27.03M	1.21%	451.69K	New	451.69K	$59.84
iShares TIPS Bond ETF	TIP	22.27M	1.00%	191.09K	27.09%	40.74K	$116.57	$110.16	$131.37	$110.07	19.58B	0.11%
Tiffany & Co New		21.66M	0.97%	162.04K	New	162.04K	$133.65
Iberiabank Corp		19.80M	0.89%	264.54K	New	264.54K	$74.83
eBay Inc.	EBAY	16.07M	0.72%	444.97K	New	444.97K	$36.11	$42.66	$81.19	$40.52	23.44B	0.08%
Financial Select Sector SPDR Fund	XLF	15.74M	0.71%	511.50K	New	511.50K	$30.78	$33.36	$41.7	$30.37	29.47B	0.06%
Marathon Petroleum Corporation	MPC	15.08M	0.68%	250.27K	New	250.27K	$60.25	$96.14	$114.35	$56.08	47.94B	0.05%
The Walt Disney Company	DIS	13.23M	0.59%	91.46K	-72.20%	-237.52K	$144.63	$110.77	$185.9	$90.23	201.94B	0.01%
Edwards Lifesciences Corporation	EW	12.21M	0.55%	52.33K	New	52.33K	$233.29	$94.88	$131.73	$85.58	58.82B	0.01%
Interxion Holding Nv		12.12M	0.54%	144.59K	New	144.59K	$83.81
CME Group Inc.	CME	12.04M	0.54%	60.01K	-0.09%	-54	$200.71	$190.77	$256.94	$185.79	68.57B	0.02%
Charter Communications, Inc.	CHTR	11.93M	0.53%	24.59K	New	24.59K	$485.07	$376.00	$769.35	$373.93	60.41B	0.02%
Arqule Inc		11.42M	0.51%	572.36K	New	572.36K	$19.96
Zendesk, Inc.	ZEN	11.14M	0.50%	145.34K	-18.88%	-33.82K	$76.63	$76.59	$136.3	$54.16	9.45B	0.12%
Phillips 66	PSX	10.84M	0.49%	97.30K	New	97.30K	$111.41	$81.87	$111.28	$63.19	39.38B	0.02%

Holdings Breakdown

Disclaimer: Investor holdings are derived from 13F filings which are required to be filed by all institutional investment managers with at least $100 million in assets under management. Limitations to this data include but are not limited to: (1) SEC does not review 13Fs for accuracy or completeness, (2) cash, foreign stocks, short positions, and a variety of other assets are not required to be reported, (3) 13Fs are often filed 45 days after the end of the quarter, by which time a manager's positions and outlook could have changed significantly, (4) the market value does not tell us at what price the manager acquired the asset, and (5) data is only available starting mid 2013. Please do your own research before drawing any conclusions from this data.